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http://dx.doi.org/10.1016/j.jds.2012.0Abstract Background/purpose: Regeneration of bony tissue is a major goal in periodontal
and implant surgery. The adhesion efficacy of osteogenic cells to bone substitutes is a deter-
minant for osteogenesis. The adsorbed proteins have a significant impact on the behavior of
cells and the biological activity of the grafting materials. The aim of the present study was
to compare the adhesion ability of different grafting materials with and without extracellular
matrix (ECM) protein coating.
Materials and methods: MG63 human osteosarcoma cells were cocultured with the same vol-
ume of different bone substitutes (Bio-Oss, Cerasorb, MBCP, and BoneCeramic). The nonadhe-
sion cells in the suspension were counted. The medium pH values were measured. The viability
of attached cells was measured by the dye WST-1 (water-soluble tetrazolium salts-1). The
same procedures for cell viability were repeated for each bone substitute coated with ECM
proteins (fibronectin, vitronectin, type I collagen) separately.
Results: Adsorption of ECM proteins increased cell adhesion to the bone substitutes. Vitronec-
tin and fibronectin increased cell attachment to Cerasorb or BoneCeramic significantly more
than type I collagen did. Type I collagen was better in increasing cell attachment to Bio-
Oss, which had the lowest attached cell count both on dry material and with protein coating.
Conclusion: The results indicated that ECM proteins increased cell attachment to bone substi-
tutes in vitro. The preferential affinity of different bone substitutes to certain ECM proteinsof Medical Education and Research, Kaohsiung Veterans General Hospital, 386 Ta-Chung First Road,
ov.tw (C.-R. Jan).
iation for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
3.026
400 L.-L. Tseng et alwas evident. Cerasorb and BoneCeramic had better MG63 human osteosarcoma cell adhesion
ability than Bio-Oss and MBCP.
Copyright ª 2013, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.Introduction
Osteoconduction of bone substitutes are related to the
adherence of osteoblasts to the surface of the substitutes1
as well as the cell’s migration and proliferation later along
these scaffolds. Accordingly, the adhesion efficacy of
osteogenic cells is critical.2,3 Cell adhesion is the first
interaction between cells and materials and the quality of
this phase influences further cell functions.4 In fact,
immediately after the bone substitute is implanted into an
organism or comes into contact with cell culture environ-
ments, protein adsorption to its surface occurs. These
proteins include fibronectin, vitronectin, fibrinogen, im-
munoglobulins, albumin, and others. The adsorption takes
place within seconds, long before the first cells reach the
surface. Hence, cells almost never come into direct contact
with the material surface; rather, they interact with the
layer of adsorbed proteins. This layer mediates the cell
adhesion and provides signals to the cell through the cell
adhesion receptors, determining the cellular response to
the bone substitute.5 Fibronectin, an abundant glycopro-
tein in the extracellular matrix (ECM), is present at its
highest concentration during osteogenesis. It binds to os-
teoblasts preferentially and more strongly than other ECM
proteins.6 It contributes to osteoblastic adhesion, differ-
entiation, and matrix mineralization.7,8 Vitronectin also has
high affinity for osteoblasts as compared to other cells. This
would generate a clinical advantage in osteogenesis by
preventing connective tissue formation after grafting ma-
terial was implanted. Both fibronectin and vitronectin
could bind to the integrins on the surface of the osteoblast,
which improves cell attachment to the bone substitutes or
spreads cells on the surface of these biomaterials.9
Expressed from early stages of differentiation onwards,
type I collagen is another ECM protein that is essential for
bone formation and matrix production.10 The spontaneous
and competitive adsorption of certain proteins from sur-
rounding body fluids after implantation has a significant
impact on the behavior of cells.11 The type, amount, and
geometrical conformation of adsorbed proteins influence
further cell functions and strongly depend on the physico-
chemical properties of the material surface, such as its
wettability, electrical charge, surface roughness, and
topography, mechanical properties (rigidity or flexibility),
crystallinity, porosity, solubility, pH, or presence of certain
atoms or chemical functional groups.4 This investigation
was to compare the adhesion efficacies of four bone sub-
stitutes with and without coating of the above-mentioned
three ECM proteins. Among the four substitutes of clinical
interest, one is Bio-Oss (cancellous bovine bone), a non-
synthetic xenograft, and the rest are synthetic, which are
Cerasorb [pure phase b-tricalcium phosphate (TCP)],
BoneCeramic [40% b-TCP, 60% hydroxyapatite (HA)], andMBCP (40% b-TCP, 60% HA). In addition, the pH values of
each medium were monitored because the adhesion sub-
strates can release calcium and phosphate ions that induce
strong alkalization of the cell culture media leading to cell
death in the conventional static cell culture system.
Materials and methods
Cell culture osteoblast-like cells (MG63) were cultured in
sterile Falcon wells (Becton Dickinson, Franklin Lakes, NJ,
USA) containing ATCC-formulated Eagle’s Minimum Essen-
tial Medium (Catalog No. 30-2003), which was supple-
mented with 10% fetal bovine serum (FBS) (Sigma Chemical
Co., St. Louis, MO, USA) and antibiotics (penicillin 100 U/mL
and streptomycin 100 mg/mL; Sigma Chemical Co.). Medium
renewal was performed two to three times per week. The
cultures were maintained in a 37C atmosphere of 95% air
and 5% carbon dioxide. Observation of MG63 cell attach-
ment cells at a density of 2  104 were seeded on culture
plates. Half of the plates were coated with polystyrene and
the rest without. Cell morphology was observed directly
under a microscope (Olympus (100 Lauman Lane, Suite A
Hicksville, NY 11801), 10  20 magnification) after 24 hours.
Cell attachment to bone substitutes 100 mL of MG63 cells at
a density of 2  104 were seeded into culture wells coated
with and without polystyrene as the control group. The
experimental group consisted of four wells without poly-
styrene coating. Each well contained different bone sub-
stitutes of 100 mm3. This volume was used to represent a
clinical alveolar bony defect. Those bone substitutes were
Bio-Oss (Geistlich, Wolhuser, Switzerland, 0.25e1 mm
granules), Cerasorb (Riemser Arzneimittel AG, Germany,
500e1000 microns), MBCP (Citagenix, Laval, Canada,
0.5e1 mm granules), and BoneCeramic (Straumann, Wol-
husen, Switzerland, 500e1000 mm). After 24 hours, all of
the suspension medium of each well was aspirated to count
floating cells. The pH value of the medium was measured by
a pH meter (Mettler-Toledo SevenEasy, Wolhusen,
Switzerland). Cell viability was assayed by using a colori-
metric assay. The principle was based on the cleavage of
WST-1 (water-soluble tetrazolium salts-1) tetrazolium salt
(Roche, Mannheim, Germany) by mitochondrial de-
hydrogenases in viable cells, which changed absorbance.
Ten microliters of WST-1 and 90 mL new medium were
added into each well after the suspension medium was
aspirated. The wells were incubated for a further 2 hours in
a humidified atmosphere at 37C. The numbers of viable
cells were determined by measuring the absorbance of
samples (A450) using an enzyme-linked immunosorbent
assay (ELISA) reader. Experiments were repeated six times
in six replicates. MG63 cells attachment to bone substitutes
that were wetted with ECMs. The bone substitutes were
wetted with 100 mL of 99% ethanol for 1 hour at room
Figure 2 Microscope observation of MG63 cells in a culture
plate without polystyrene coating after 24 hours (Olympus;
magnification 200). A few attached cells in a spindle shape
were visible. Most of the cells were dead and their shape
irregular. There were also a few nonattached viable cells that
retained their round shape. Data are representative of four
experiments.
Bone substitutes adhered to osteoblasts 401temperature. Then, ethanol was discarded. The wetted
bone substitutes were washed with 100 mL of PBS at room
temperature three times within 30 minutes. One hundred
microliters of 5 mg/mL fibronectin (Sigma), vitronectin
(Sigma), and type I collagen (Sigma) were each mixed with
100 mL of 10% FBS (Gibco BRL, Grand Island, NY, USA) and
were added into the washed bone substitutes, respectively.
They were left stand at 4C for 12 hours. The fluid of FBS
and the protein were then removed, and 100 mL of PBS was
used to rinse the bone substitutes three times in 5 minutes
under gentle agitation. Finally, the protein-wetted bone
substitutes were put into new wells. One hundred microli-
ters of 2  104 MG63 cells were seeded into each well. The
control group had MG63 cells only. All the wells were not
coated with polystyrene. After 24 hours, the culture me-
dium that contained nonattached cells was discarded. The
90-mL new culture medium and 10 mL WST-1 were added.
Cells were incubated for 2 hours in a humidified atmo-
sphere at 37C. The numbers of viable cells were deter-
mined by measuring the absorbance Amax 450 nm with an
ELISA reader. Experiments were repeated six times in six
replicates. Statistics data are reported as representative or
mean  standard error of the mean (SEM) of six experi-
ments. Data were analyzed by two-way analysis of vari-
ances (ANOVA) using the Statistical Analysis System (SASR;
SAS Institute Inc., Cary, NC, USA). A P value < 0.05 was
considered significant.
Results
Cell attachment was noticeable after 24 hours in a culture
plate coated with polystyrene. As shown in Fig. 1, the circle
shape represented a nonattached viable cell, the spindle an
attached cell, and the irregular a dead cell. By contrast,
cell attachment was not evident in a culture plate without
polystyrene coating, as indicated in Fig. 2 where the spin-
dle shapes were hardly found. As shown in Fig. 3, the sus-
pension cell count of Bio-Oss was the highest. The cellFigure 1 Microscope observation of MG63 cells in a culture
plate coated with polystyrene after 24 hours (Olympus;
magnification 200). Most of the cells were attached and took
on a spindle shape. A few nonattached viable cells retained a
round form. Data are representative of four experiments.count of MBCP was higher than BoneCeramic and Cerasorb.
Fig. 4 indicates that there was no difference in cell adhe-
sion efficacies between Cerasorb and BoneCeramic; both of
them were significantly better than MBCP, and MBCP was
better than Bio-Oss. The pH values of the media aspirated
from each well were between 7.93 and 8.08 as illustrated in
Fig. 5. The pH values of Bio-Oss and BoneCeramic were
higher than the others. Fig. 6 shows that type I collagen
significantly increased the cell attachment extent ofFigure 3 Suspension cell count after 24 hours. The suspen-
sion medium of each well was aspirated for counting of floating
cells. Data are mean  standard error of the mean (SEM) of six
experiments. The nonpolystyrene-coated well served as the
control. The wells containing all the bone substitutes were
nonpolystyrene-coated. * P < 0.05 compared to control.
Figure 4 Cell viability on materials. Cells were cultured with
100 mm3 of bone substitute for 24 hours. Data are expressed as
percentage of control. The nonpolystyrene-coated well served
as control. Data are mean  standard error of the mean (SEM)
of six experiments. The wells containing all the bone sub-
stitutes were nonpolystyrene-coated. * P < 0.05 compared to
control.
Figure 6 Cell viability on type I collagen-adsorbed bone
substitutes. Cells were cultured with 100 mm3 of type I
collagen-wetted bone substitutes for 24 hours. Data are
expressed as percentage of control. The “control” contained
the medium only. Data are mean  standard error of the mean
(SEM) of six experiments. *P < 0.05 compared to control.
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ences between BoneCeramic and Cerasorb. Cell attach-
ment extent in the order from high to low is BoneCeramic,
Cerasorb, MBCP, and Bio-Oss. In Fig. 7, vitronectin showed a
trend the same as that of type I collagen and had the same
order. Fibronectin could also increase the cell attachment
extent of Cerasorb and BoneCeramic (Fig. 8). By comparing
the cell attachment extent of the protein-wetted boneFigure 5 pH values of the medium after 24 hours. The
“control” contained the culture medium only. The “cells” were
added with MG63 cells, and the rest with the cells and the
respective bone substitute. Data are mean  standard error of
the mean (SEM) of six experiments. *P < 0.05 compared to
control.substitutes with that of the notwetted in Table 1, the
following findings were evident. Type I collagen increased
the cell attachment extent of Bio-Oss. All three ECM pro-
teins increased the cell attachment extent of Cerasorb. The
order from high to low was fibronectin, vitronectin, and
type I collagen. Neither of the three ECM proteins could
increase the cell adhesion capacity for MBCP. The cell
attachment extent of BoneCeramic was doubled by vitro-
nectin and fibronectin, and was nearly doubled by type I
collagen. The bone substitutes wetted with the selected
ECM proteins that achieved the largest cellular attachmentFigure 7 Cell viability on vitronectin-adsorbed bone sub-
stitutes. Cells were cultured with 100 mm3 of vitronectin-
wetted bone substitutes for 24 hours. Data are expressed as
percentage of control. The “control” contained the medium
only. Data are mean  standard error of the mean (SEM) of six
experiments. *P < 0.05 compared to control.
Figure 8 Cell viability on fibronectin-adsorbed bone sub-
stitutes. Cells were cultured with 100 mm3 of fibronectin-
wetted bone substitutes for 24 hours. Data are expressed as
percentage of control. The “control” contained the medium
only. Data are mean  standard error of the mean (SEM) of six
experiments. * P < 0.05 compared to control.
Bone substitutes adhered to osteoblasts 403gains compared to those without ECM protein coating were
as follows: BoneCeramic increased from 108% to 238% with
Vitronectin, Cerasorb from 118% to 232% with fibronectin,
and Bio-Oss from 11% to 15% with type I collagen.
Discussion
Human osteoblasts are anchorage-dependent cells. The
focal contact between the intracellular cytoskeleton of
these cells and ECM proteins can initiate signal trans-
mission. These signals are further transmitted to the
cytosol and nucleus and then they go through cell prolif-
eration, matrix formation, maturation, and mineralization.
The MG63 cell is a permanent human osteosarcoma cell
line. It has been used as an osteoblast model to study cell
adhesion.12,13 Although a permanent cell line would reflect
adaptation to the in vitro environment, this behavior did
not become an issue in the 24-hour time frame of our study.
In a conventional static cell culture system, the high
solubility of TCP bone substitutes would release calcium
and phosphate ions continuously. The local accumulation of
these ions would increase the alkalinity of the culture
medium to a level that could be toxic to cultured cells.14 It
was also reported that Bio-Oss, due to the formation of CaOTable 1 Comparison of cellular attachment on the bone substit
ones.
Bone substitutes Nonwetted þType I
BioOss 11.1  0.4 14.9 
Cerasorb 118.6  12.4 156.0 
MBCP 39.8  4.3 23.6 
Bone Ceramic 108.1  9.4 187 
Data are expressed as percentage of the total attachment (100%) ofduring the sintering process, could cause an alkaline pH in
contact with liquids, which is not favorable for cellular
attachment. By contrast, in healthy tissues, the pH values
could be promptly regulated between 7.35 and 7.45.15 In
our study, the pH values of all tested groups were between
7.93 and 8.08 (Fig. 5), which were a bit higher than that of
body fluid. However, the promineralization activity of os-
teoblasts had been reported to increase at alkaline extra-
cellular pH, indicating that the growth of osteoblasts was
favored in slightly more alkaline condition than the “phys-
iological” pH of 7.4. Furthermore, the pH value of 8.5 was
shown to be optimum for alkaline phosphate activity.16
Therefore, the pH values of Bio-Oss and BoneCeramic
samples, although higher among the tested groups, were
lower than 8.5 and were not toxic to cells.17 In addition to
being affected by the pH value, osteoblasts would display
different morphological changes while being cultured with
different material surfaces. The surface roughness, micro-,
and nano-topography of materials could affect cell
morphology, cytoskeleton spreading, proliferation, and
differentiation. In particular, polystyrene is one of the most
widely used polymeric materials for cell culturing and as
scaffolds for tissue regeneration. The attachment of oste-
oblasts to bone substitutes would not be as good as to
polystyrene culture plates.18 This was verified by the result
of the cell viability on materials (Fig. 4). However, to
exclude the possible interference of polystyrene, the
ensuing experiments used the wells without coating
instead. Data in Fig. 4 led to the impression that MG63 cells
adhered to MBCP poorly and to Bio-Oss even worse.
Although MBCP and BoneCeramic are both b-TCP/HA (40%/
60%), the MG63 cells adhere to MBCP far less than Bone-
Ceramic. This biological outcome might result from the
subtle manufacturing differences of the following param-
eters: homogeneity of the TCP/HA, crystallinity of HA,
sintering temperature, mean size of macropores, and per-
centage of total porosity. For example, BoneCeramic is 90%
porous, Cerasorb (500e1000 mm) has a total porosity of 80%,
and MBCP has a 70% overall porosity. The larger surface
area allows interaction of the bone substitutes with bone-
forming cells, thus promoting cell adhesion. Bio-Oss is
deproteinized, sterilized bovine bone. The deproteination
and inactivation of pathogen processes of Bio-Oss were
shown to have adverse biological effects on cells due to
oxidative stress.19 Vitronectin and fibronectin increased the
cell attachment of BoneCeramic and Cerasorb but they did
not provide the same effect for Bio-Oss. Fibronectin even
had a negative impact on Bio-Oss. Type I collagen was the
only one of the three proteins that could enhance the cell
adhesion capacity of Bio-Oss. However, it reduced the cellutes versus on the extracellular matrix (ECM) protein-wetted
collagen þFibronectin þVitronectin
0.8 6.0  0.5 9.8  0.9
12.8 232.0  14.5 189  13.6
1.6 33.2  6.5 36.2  4.7
2.4 216.0  6.5 238.0  11.3
the MG63 cells in noncoated wells.
404 L.-L. Tseng et alattachment of MBCP. These variations might result from the
different affinities of the proteins to the bone substitutes.
The findings suggest potential applications in surface
modification of different bone substitutes for osteo-
conduction. Further studies are needed to investigate the
affinities of the ECM proteins to the bone substitutes and to
osteoblasts. Attention should also be given to possible in-
teractions among the ECM proteins that might be syner-
gistic in increasing adhesion efficacy. From the perspective
of an ideal bone substitute, the adhesion efficacy of Bio-Oss
was far lower than that of Cerasorb and BoneCeramic,
although it could be improved by type I collagen in this
study and other investigations.20e22 Bio-Oss did not yield
the kind of clinical effectiveness that was displayed by
BoneCeramic and Cerasorb, which was surprising for a bone
substitute.23,24 This might be because the TCP-based ma-
terials (MBCP, Cerasorb, and BoneCeramic) resorbed faster
causing micromovements and inflammatory reactions
induced by chemical dissolution of TCP. Both factors might
affect bone formation negatively in vivo, whereas Bio-Oss
did not. Further studies are needed to investigate how
new bone is generated after osteoblasts attach to bone
substitutes, that is through proliferation, maturation, and
mineralization, and the differences between synthetic
(BoneCeramic and Cerasorb) and nonsynthetic (Bio-Oss)
bone substitutes.
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